BCLS II Investco (GP), LLC's Net Worth

$1.38 Million

Estimate Recalculated Jul 19, 2024 03:34PM EST

Who is BCLS II Investco (GP), LLC?

BCLS II Investco (GP), LLC has an estimated net worth of $1.38 Million. This is based on reported shares across multiple companies, which include Xilio Therapeutics, Inc., and Solid Biosciences Inc..

SEC CIK

BCLS II Investco (GP), LLC's CIK is 0001819101

Past Insider Trading and Trends

2021 was BCLS II Investco (GP), LLC's most active year for acquiring shares with 4 total transactions. BCLS II Investco (GP), LLC's most active month to acquire stocks was the month of November. 2021 saw BCLS II Investco (GP), LLC paying a total of $410,161.39 for 42,469 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.6382

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1.54%
42.47K
$9.66
$410,161.39
2.81M
Dec 8 - Dec 10
Form 3
—
0
—
—
0
No matching records found

Solid Biosciences Inc. (SLDB) Snapshot price: $7.26

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+28.88%
904.16K
$5.53
$5,000,004.80
4.03M
Jan 11
Form 3
—
0
—
—
0
No matching records found

NewAmsterdam Pharma Co N.V. (NAMS) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found